Cindome Pharma, Inc.

This Phase 2 trial tests whether CIN-102 (deudomperidone) can reduce nausea in adults with idiopathic gastroparesis, a condition where the stomach empties slowly. Over 400 participants will take either 10 mg, 15 mg, or a placebo twice daily for 12 weeks. Researchers will track sy…

This study tested an experimental drug called CIN-102 (deudomperidone) to see if it can reduce nausea, vomiting, and other stomach symptoms in adults with diabetic gastroparesis—a condition where the stomach empties too slowly. About 382 participants took either the drug or a pla…